{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "firstTradeDateMilliseconds": 1624320000000, "priceHint": 2, "epsTrailingTwelveMonths": -67.7, "epsForward": 62.6, "sharesOutstanding": 11759400, "bookValue": 221.866, "fiftyDayAverage": 297.38, "fiftyDayAverageChange": -7.380005, "fiftyDayAverageChangePercent": -0.02481675, "twoHundredDayAverage": 344.24, "twoHundredDayAverageChange": -54.23999, "twoHundredDayAverageChangePercent": -0.15756446, "marketCap": 3410225920, "forwardPE": 4.632588, "priceToBook": 1.3070953, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": 0.0, "regularMarketPrice": 290.0, "marketState": "PREPRE", "exchange": "JPX", "shortName": "PERSEUS PROTEOMICS INC", "longName": "Perseus Proteomics Inc.", "messageBoardId": "finmb_26077826", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "market": "jp_market", "esgPopulated": false, "regularMarketChange": 0.0, "regularMarketTime": 1683872101, "regularMarketDayHigh": 291.0, "regularMarketDayRange": "287.0 - 291.0", "regularMarketDayLow": 287.0, "regularMarketVolume": 44600, "regularMarketPreviousClose": 290.0, "bid": 288.0, "ask": 290.0, "fullExchangeName": "Tokyo", "financialCurrency": "JPY", "regularMarketOpen": 289.0, "averageDailyVolume3Month": 127743, "averageDailyVolume10Day": 87570, "fiftyTwoWeekLowChange": 9.0, "fiftyTwoWeekLowChangePercent": 0.03202847, "fiftyTwoWeekRange": "281.0 - 627.0", "fiftyTwoWeekHighChange": -337.0, "fiftyTwoWeekHighChangePercent": -0.53748006, "fiftyTwoWeekLow": 281.0, "fiftyTwoWeekHigh": 627.0, "earningsTimestamp": 1684148340, "earningsTimestampStart": 1684148340, "earningsTimestampEnd": 1684148340, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "4882.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4-7-6, Komaba Meguro-ku", "address2": "Meguro-ku", "city": "Tokyo", "zip": "153-0041", "country": "Japan", "phone": "81 3 5738 1705", "fax": "81 3 3481 5760", "website": "https://www.ppmx.com", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Perseus Proteomics Inc., a drug discovery bio-venture company, develops antibody drugs against cancer and other diseases in Japan. The company is involved in the antibody discovery, antibody engineering, target discovery, and functional protein expression activities; and antibody research support activities comprising mouse hybridoma sequencing, recombinant protein production, and contract antibody research activities, as well as development, manufacture, and supply of antibody products. Its product pipeline includes PPMX-T001 for treating liver cancer; PPMX-T002 for solid tumors; PPMX-T003 to treat hematologic cancer; and PPMX-T004 for solid tumor. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Takuya  Yokokawa", "age": 62, "title": "Pres, CEO & Director", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Tadashi  Matsuura", "age": 63, "title": "Chief Technology Officer & Director", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Shinichi  Suzukawa", "age": 67, "title": "Head of Admin. Dept, Exec. Officer & Director", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}